Smart Chondroitin Sulfate Micelles for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Metastasis

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA. 2022;72:7–33. doi:10.3322/caac.21708
   Google Scholar
• Jyotsana N, Zhang Z, Himmel LE, Yu F, King MR. Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection. Sci Adv. 2019;5:eaaw4197. doi:10.1126/sciadv.aaw4197
   PubMed Web of Science ®Google Scholar
• Wang T-W, Yeh C-W, Kuan C-H, et al. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy. Acta Biomater. 2017;58:54–66. doi:10.1016/j.actbio.2017.06.008
   PubMed Web of Science ®Google Scholar
• Yu J, Mu Q, Fung M, Xu X, Zhu L, Ho RJY. Challenges and opportunities in metastatic breast cancer treatments: nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response. Pharmacol Ther. 2022;236:108108.
   PubMed Web of Science ®Google Scholar
• Tang S, Meng Q, Sun H, et al. Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer. Biomaterials. 2017;114:44–53.
   PubMed Web of Science ®Google Scholar
• Jabbari A, Yaghoobi E, Azizollahi H, et al. Design and synthesis of a star-like polymeric micelle modified with AS1411 aptamer for targeted delivery of camptothecin for cancer therapy. Int J Pharm. 2022;611:121346.
   PubMedGoogle Scholar
• Liu Y, Yu F, Dai S, et al. All-trans retinoic acid and doxorubicin delivery by folic acid modified polymeric micelles for the modulation of Pin1-mediated DOX-induced breast cancer stemness and metastasis. Mol Pharm. 2021;18:3966–3978.
   PubMedGoogle Scholar
• Kaur J, Mishra V, Singh SK, et al. Harnessing amphiphilic polymeric micelles for diagnostic and therapeutic applications: breakthroughs and bottlenecks. J Control Release. 2021;334:64–95.
   PubMed Web of Science ®Google Scholar
• Ghosh B, Biswas S. Polymeric micelles in cancer therapy: state of the art. J Control Release. 2021;332:127–147.
   PubMed Web of Science ®Google Scholar
• Banstola A, Poudel K, Kim JO, Jeong J-H, Yook S. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. J Control Release. 2021;337:505–520. doi:10.1016/j.jconrel.2021.07.038
   PubMed Web of Science ®Google Scholar
• Chen WH, Yu X, Cecconello A, Sohn YS, Nechushtai R, Willner I. Stimuli-responsive nucleic acid-functionalized metal-organic framework nanoparticles using pH- and metal-ion-dependent DNAzymes as locks. Chem Sci. 2017;8:5769–5780. doi:10.1039/C7SC01765K
   PubMed Web of Science ®Google Scholar
• Sikder A, Vambhurkar G, Amulya E, et al. Advancements in redox-sensitive micelles as nanotheranostics: a new horizon in cancer management. J Control Release. 2022;349:1009–1030. doi:10.1016/j.jconrel.2022.08.008
   PubMed Web of Science ®Google Scholar
• Liu N, Tan Y, Hu Y, et al. A54 peptide modified and redox-responsive glucolipid conjugate micelles for intracellular delivery of doxorubicin in hepatocarcinoma therapy. ACS Appl Mater Interfaces. 2016;8:33148–33156. doi:10.1021/acsami.6b09333
   PubMed Web of Science ®Google Scholar
• Song Q, Wang X, Wang Y, et al. Reduction responsive self-assembled nanoparticles based on disulfide-linked drug-drug conjugate with high drug loading and antitumor efficacy. Mol Pharm. 2016;13:190–201. doi:10.1021/acs.molpharmaceut.5b00631
   PubMed Web of Science ®Google Scholar
• Ma ZC, Wu JP, Sun MC, Li BY, Yu X. Disulfur-bridged polyethyleneglycol/DOX nanoparticles for the encapsulation of photosensitive drugs: a case of computational simulations on the redox-responsive chemo-photodynamic drug delivery system. RSC Adv. 2021;11:37988–37994. doi:10.1039/D1RA05645J
   PubMed Web of Science ®Google Scholar
• Liu HX, Wu SQ, Yu JM, et al. Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin. Mater Sci Eng C Mater Biol Appl. 2017;75:55–63. doi:10.1016/j.msec.2017.02.030
   PubMed Web of Science ®Google Scholar
• Cai S, Xie X, Yuan Q, et al. Preparation and evaluation of reduction-responsive micelles based on disulfide-linked chondroitin sulfate A-tocopherol succinate for controlled antitumour drug release. J Pharm Pharmacol. 2021;73:1405–1417. doi:10.1093/jpp/rgab096
   PubMed Web of Science ®Google Scholar
• Lee J-Y, Chung S-J, Cho H-J, Kim -D-D. Phenylboronic acid-decorated chondroitin sulfate A-based theranostic nanoparticles for enhanced tumor targeting and penetration. Adv Funct Mater. 2015;25:3705–3717. doi:10.1002/adfm.201500680
   Web of Science ®Google Scholar
• Yu JM, Liang L, Xie X, et al. Multifunctional nanoparticles codelivering doxorubicin and amorphous calcium carbonate preloaded with indocyanine green for enhanced chemo-photothermal cancer therapy. Int J Nanomedicine. 2023;18:323–337. doi:10.2147/IJN.S394896
   PubMed Web of Science ®Google Scholar
• Yu JM, Xie X, Xu XY, et al. Development of dual ligand-targeted polymeric micelles as drug carriers for cancer therapy in vitro and in vivo. J Mater Chem B. 2014;2:2114–2126. doi:10.1039/c3tb21539c
   PubMed Web of Science ®Google Scholar
• Zhang XB, Wang Y, Wei GQ, Zhao JY, Yang G, Zhou SB. Stepwise dual targeting and dual responsive polymer micelles for mitochondrion therapy. J Control Release. 2020;322:157–169. doi:10.1016/j.jconrel.2020.03.011
   PubMed Web of Science ®Google Scholar
• Li X, Yu Y, Ji Q, Qiu LY. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin- linked polymer composite micelles. Nanomed Nanotechnol Biol Med. 2015;11:175–184. doi:10.1016/j.nano.2014.08.013
   PubMed Web of Science ®Google Scholar
• Li L, Hou J, Liu X, et al. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas. Biomaterials. 2014;35:3840–3850. doi:10.1016/j.biomaterials.2014.01.019
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen R, Fang X, Chen F, Wang Y, Chen M. Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles for enhanced delivery and antitumor efficacy of paclitaxel. Nano Res. 2015;8:201–218. doi:10.1007/s12274-014-0619-4
   Web of Science ®Google Scholar
• Yang S, Ren Z, Chen M, et al. Nucleolin-targeting AS1411-aptamer-modified graft polymeric micelle with dual pH/redox sensitivity designed to enhance tumor therapy through the codelivery of doxorubicin/TLR4 siRNA and suppression of invasion. Mol Pharm. 2018;15:314–325. doi:10.1021/acs.molpharmaceut.7b01093
   PubMedGoogle Scholar
• Carvalho J, Lopes-Nunes J, Vialet B, et al. Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro. Nanomed Nanotechnol Biol Med. 2021;36:102429. doi:10.1016/j.nano.2021.102429
   PubMed Web of Science ®Google Scholar
• Zhang F, Correia A, Makila E, et al. Receptor-mediated surface charge inversion platform based on porous silicon nanoparticles for efficient cancer cell recognition and combination therapy. ACS Appl Mater Interfaces. 2017;9:10034–10046. doi:10.1021/acsami.7b02196
   PubMed Web of Science ®Google Scholar
• Mei L, Liu Y, Xia C, Zhou Y, Zhang Z, He Q. Polymer-drug nanoparticles combine doxorubicin carrier and heparin bioactivity functionalities for primary and metastatic cancer treatment. Mol Pharm. 2017;14:513–522. doi:10.1021/acs.molpharmaceut.6b00979
   PubMed Web of Science ®Google Scholar
• Chen Y, Yue Q, De G, et al. Inhibition of breast cancer metastasis by paclitaxel-loaded pH responsive poly (β-amino ester) copolymer micelles. Nanomedicine. 2017;12:147–164. doi:10.2217/nnm-2016-0335
   PubMed Web of Science ®Google Scholar
• Ravar F, Saadat E, Gholami M, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10–22. doi:10.1016/j.jconrel.2016.03.012
   PubMed Web of Science ®Google Scholar
• Li J, Huo M, Wang J, et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials. 2012;33:2310–2320. doi:10.1016/j.biomaterials.2011.11.022
   PubMed Web of Science ®Google Scholar
• Li H, Zhang P, Luo J, et al. Chondroitin sulfate-linked prodrug nanoparticles target the Golgi apparatus for cancer metastasis treatment. ACS Nano. 2019;13:9386–9396. doi:10.1021/acsnano.9b04166
   PubMed Web of Science ®Google Scholar
• Chen X, Chen J, Li B, et al. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: in vitro drug release and in vivo pharmacokinetics assessment. J Colloid Interface Sci. 2017;490:542–552.
   PubMed Web of Science ®Google Scholar
• Cai D, Gao W, He B, et al. Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Biomaterials. 2014;35:2283–2294. doi:10.1016/j.biomaterials.2013.11.088
   PubMed Web of Science ®Google Scholar
• Xu W, Siddiqui IA, Nihal M, et al. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials. 2013;34(21):5244–5253. doi:10.1016/j.biomaterials.2013.03.006
   PubMed Web of Science ®Google Scholar
• Zavvar T, Babaei M, Abnous K, et al. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model. Int J Pharm. 2020;578:119091.
   PubMedGoogle Scholar
• Zhang XQ, Huang YM, Song HL, et al. Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics. J Control Release. 2020;328:454–469.
   PubMed Web of Science ®Google Scholar
• Dancy JG, Wadajkar AS, Connolly NP, et al. Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer. Sci Adv. 2020;6:eaax3931.
   PubMed Web of Science ®Google Scholar
• Yu S, Ding J, He C, Cao Y, Xu W, Chen X. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy. Adv Healthcare Mater. 2014;3:752–760.
   Web of Science ®Google Scholar
• Chen W, Zhong P, Meng F, et al. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. J Control Release. 2013;169:171–179.
   PubMed Web of Science ®Google Scholar
• Pachmayr E, Treese C, Stein U. Underlying mechanisms for distant metastasis - Molecular biology. Visc Med. 2017;33:11–20.
   PubMed Web of Science ®Google Scholar
• Rosenberg JE, Bambury RM, Van Allen EM, et al. A Phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma. Invest New Drugs. 2014;32:178–187.
   PubMed Web of Science ®Google Scholar
• Sun H, Meng Q, Tang S, et al. Inhibition of breast cancer metastasis by pluronic copolymers with moderate hydrophilic-lipophilic balance. Mol Pharm. 2015;12:3323–3331.
   PubMed Web of Science ®Google Scholar
• Jiang K, Song X, Yang L, et al. Enhanced antitumor and anti-metastasis efficacy against aggressive breast cancer with a fibronectin-targeting liposomal doxorubicin. J Control Release. 2018;271:21–30.
   PubMed Web of Science ®Google Scholar
• Torchilin V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 2011;63:131–135.
   PubMed Web of Science ®Google Scholar